Containment
BSL-2 CDMOs
Compare CDMOs with BSL-2 containment facilities for vaccine production, viral vector manufacturing, and biologics involving moderate-risk organisms.
369 companies listed
About BSL-2 Manufacturing
BSL-2 (Biosafety Level 2) facilities are designed for work with moderate-risk biological agents that can cause disease in humans but have available treatments. In pharmaceutical manufacturing, BSL-2 is required for: live-attenuated vaccine production, lentiviral vector manufacturing, certain viral challenge studies, and production involving recombinant organisms with moderate risk.
BSL-2 facility requirements include: restricted access during operations, self-closing and lockable doors, directional airflow (inward), biological safety cabinets for aerosol-generating procedures, autoclave availability within the facility, emergency shower and eyewash stations, and decontamination procedures for equipment and waste. IBC (Institutional Biosafety Committee) oversight is required for BSL-2 operations.
Companies (369)
P
PharmaPharma Ltd.
United Kingdom
PharmaPharma Ltd. is a leading contract development and manufacturing organization headquartered in United Kingdom. We specialize in Contract Research Organization (CRO), Fill/Finish with state-of-the-art facilities serving clients globally.
Cytotoxic / ADC HandlingHigh-Potency APISterile Fill/Finish
7bridges (the7bridges.com)
United Kingdom
7bridges (the7bridges.com) is a pharmaceutical CDMO offering comprehensive services.
Small Molecule APISmall Molecule Drug ProductOral Solid Dose
Frequently Asked Questions
When is BSL-2 required for pharmaceutical manufacturing?+
BSL-2 is required when manufacturing involves: live-attenuated vaccine strains (measles, mumps, rubella, varicella), lentiviral and retroviral vectors (used in CAR-T and gene therapy manufacturing), certain recombinant organisms (depending on risk assessment), and viral seed stocks for inactivated vaccine production. The biosafety level is determined by a risk assessment of the biological agents involved.
How does BSL-2 differ from BSL-1?+
BSL-1 is suitable for well-characterized agents not known to cause disease in healthy adults (e.g., non-pathogenic E. coli for recombinant protein production). BSL-2 adds: restricted access, biosafety cabinet requirement for aerosol-generating procedures, enhanced PPE, specific training in handling pathogenic agents, and more rigorous decontamination procedures. BSL-2 also requires IBC oversight and a documented biosafety manual.
Need help finding the right CDMO?
Our AI Matchmaker analyzes your project requirements and matches you with qualified manufacturing partners. Free for buyers.
